Literature DB >> 32723565

Ca2+ as a therapeutic target in cancer.

Scott Gross1, Pranava Mallu1, Hinal Joshi1, Bryant Schultz1, Christina Go1, Jonathan Soboloff2.   

Abstract

Ca2+ is a ubiquitous and dynamic second messenger molecule that is induced by many factors including receptor activation, environmental factors, and voltage, leading to pleiotropic effects on cell function including changes in migration, metabolism and transcription. As such, it is not surprising that aberrant regulation of Ca2+ signals can lead to pathological phenotypes, including cancer progression. However, given the highly context-specific nature of Ca2+-dependent changes in cell function, delineation of its role in cancer has been a challenge. Herein, we discuss the distinct roles of Ca2+ signaling within and between each type of cancer, including consideration of the potential of therapeutic strategies targeting these signaling pathways.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium; Cancer progression; Metastasis; STIM1

Mesh:

Substances:

Year:  2020        PMID: 32723565      PMCID: PMC7412871          DOI: 10.1016/bs.acr.2020.05.003

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  506 in total

Review 1.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

2.  TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling.

Authors:  A Fiorio Pla; H L Ong; K T Cheng; A Brossa; B Bussolati; T Lockwich; B Paria; L Munaron; I S Ambudkar
Journal:  Oncogene       Date:  2011-06-20       Impact factor: 9.867

Review 3.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

Review 4.  Calcium oscillations.

Authors:  Geneviève Dupont; Laurent Combettes; Gary S Bird; James W Putney
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

5.  Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.

Authors:  Jun He; Jing-Jie Yu; Qing Xu; Lin Wang; Jenny Z Zheng; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

6.  Orai1 and STIM1 are critical for breast tumor cell migration and metastasis.

Authors:  Shengyu Yang; J Jillian Zhang; Xin-Yun Huang
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

7.  Properties of Orai1 mediated store-operated current depend on the expression levels of STIM1 and Orai1 proteins.

Authors:  N Scrimgeour; T Litjens; L Ma; G J Barritt; G Y Rychkov
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

8.  Local Ca²+ entry via Orai1 regulates plasma membrane recruitment of TRPC1 and controls cytosolic Ca²+ signals required for specific cell functions.

Authors:  Kwong Tai Cheng; Xibao Liu; Hwei Ling Ong; William Swaim; Indu S Ambudkar
Journal:  PLoS Biol       Date:  2011-03-08       Impact factor: 8.029

Review 9.  Targeting FLT3 mutations in AML: review of current knowledge and evidence.

Authors:  Naval Daver; Richard F Schlenk; Nigel H Russell; Mark J Levis
Journal:  Leukemia       Date:  2019-01-16       Impact factor: 11.528

Review 10.  Purines, purinergic receptors, and cancer.

Authors:  Francesco Di Virgilio
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701

View more
  5 in total

1.  Suppression of Ca2+ signaling enhances melanoma progression.

Authors:  Scott Gross; Robert Hooper; Dhanendra Tomar; Alexander P Armstead; No'ad Shanas; Pranava Mallu; Hinal Joshi; Suravi Ray; Parkson Lee-Gau Chong; Igor Astsaturov; Jeffrey M Farma; Kathy Q Cai; Kumaraswamy Naidu Chitrala; John W Elrod; M Raza Zaidi; Jonathan Soboloff
Journal:  EMBO J       Date:  2022-08-30       Impact factor: 14.012

2.  The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.

Authors:  Helena M Stricker; Nadine Rommerswinkel; Silvia Keil; Sandina A Gnoth; Bernd Niggemann; Thomas Dittmar
Journal:  Cell Commun Signal       Date:  2021-04-08       Impact factor: 5.712

Review 3.  The Important Role of Ion Transport System in Cervical Cancer.

Authors:  Yih-Fung Chen; Meng-Ru Shen
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

Review 4.  Repurposing of Anticancer Stem Cell Drugs in Brain Tumors.

Authors:  Hisham F Bahmad; Darine Daher; Abed A Aljamal; Mohamad K Elajami; Kei Shing Oh; Juan Carlos Alvarez Moreno; Ruben Delgado; Richard Suarez; Ana Zaldivar; Roshanak Azimi; Amilcar Castellano; Robert Sackstein; Robert J Poppiti
Journal:  J Histochem Cytochem       Date:  2021-06-24       Impact factor: 2.479

5.  Editorial: Ion Channel Signalling in Cancer: From Molecular Mechanisms to Therapeutics.

Authors:  Lin-Hua Jiang; Elena Adinolfi; Sébastien Roger
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.